Japan's genome-editing law sets a global ethics challenge
A Hiroshima University researcher contends that Japan's newly enacted law regulating human genome-edited embryos and germ cells marks a significant advance in the governance of reproductive genome editing. Tsutomu Sawai, professor at Hiroshima University's Graduate School of Humanities and Social Sciences, praises the new law for defining prohibited activities and penalties for violation but also…
Hiroshima University researcher Tsutomu Sawai noted that Japan's recently enacted law governing human genome-edited embryos and germ cells represents a significant step in regulating reproductive genome editing. The law, effective July 24, 2027, prohibits reproductive use of heritable human genome editing but permits basic research under ministerial oversight.
While Japan is already a leader in regenerative medicine and expected to lead in the ethics of such therapies, Sawai stressed the need for international coordination to prevent circumvention of prohibitions by individuals seeking procedures abroad. The law distinguishes between genome editing that affects future generations and that which does not, leaving somatic gene-editing therapies unaffected.
However, the long-term consequences of heritable genome edits cannot be verified across generations, and future children cannot consent to such interventions. Sawai emphasized that national prohibitions alone are insufficient and require international frameworks and cooperation, as people in Japan could seek genome-editing procedures in countries with weaker regulations.
The long-term nature of these decisions means that prohibitions today may not remain prohibitions forever, and future developments in science, safety, and ethics could warrant reassessment of the law and its ethical foundations.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
